- Dr. William W. Jow, M.D.
- Grant B. Walsh
- (Joseph) Shuen Chuen Chan
- Augustine Chow
- Dr. Raymond C.F. Tong
Dr. William W. Jow, M.D. – President, CEO & Medical Director
William W. Jow, M.D. received his M.D. degree from New York University in 1986. Following his surgical and urological residencies at Mount Sinai Medical Center and University of Buffalo, and fellowship training at Weill Cornell Medical College, he had served as Assistant Professor at Rutgers Robert Wood Johnson Medical School in New Jersey. Dr. Jow has been in private practice for over 20 years, and has been Chairman of Urology at Hackensack Meridian Health – Bayshore Hospital in Holmdel, New Jersey, and served on its Medical Executive Committee since 2012. He has also served as consultants to various sales and product development ventures before joining Medifocus as Scientific & Business Development Consultant and Medical Director since 2014 and as President since March 2016.
Grant B. Walsh – Chairman of the Board
Grant B. Walsh, is the managing partner and Chief Executive Officer of EC Murphy Walsh, a management consulting firm specializing in performance improvement in service, healthcare and health related organizations. EC Murphy Walsh is based in Burlington, Ontario and also has offices in Amherst, New York. Prior to establishing EC Murphy Walsh, Mr. Walsh was the President and Chief Executive Officer of St. Peter’s Health System in Ontario, Canada, a regional provider of integrated healthcare services. Previously, Mr. Walsh was an Executive regional provider of integrated healthcare services. Previously, Mr. Walsh was an Executive Vice President with Service Master Management Services, and over saw 30,000 employees servicing 10,000 client properties in 44 states. Mr. Walsh holds a BA in English and Philosophy from Roberts Wesleyan College and an MBA from Southern Illinois University and has also pursued specialized study at Harvard University, McMaster University, St. Louis University, Cornell University and the State University of New York at Buffalo. Mr. Walsh is an Adjunct Professor in the Executive Education program at the DeGroote School of Business, McMaster University and has received from the DeGroote School of Business and the Conference Board of Canada the designation as a Chartered Director. Mr. Walsh has served on numerous boards of directors.
(Joseph) Shuen Chuen Chan, MBA – Director
Mr. Chan, aged 64, is an executive director of Harmony Asset Ltd.. He obtained his MBA degree from Edinburgh Business School, Heriot-Watt University, Scotland, U.K. Mr. Chan has over 30 years of accounting and management experience in the fields of industrial manufacturing, service (hotel & charitable) industry, academia and public service. Professionally, Mr. Chan is an associate member of The Institute of Chartered Accountants in England and Wales and fellow members of The Hong Kong Institute of Certified Public Accountants, the Association of Chartered Certified Accountants and the Chartered Institute of Management Accountants as well as a member of the Certified General Accountants’ Association of Canada. Mr. Chan is an independent director of Champion Minerals Inc (TSX) since November 4, 2009, Medifocus Inc. (TSX-V) since January 29, 2010, Kaiyue International Inc. (TSX-V Capital Pool Company) since November 2009 and Yin Fu Gold Corporation (OTB, US) since September 2010.
Augustine Chow – Director
Dr. Augustine Chow, PhD, was appointed to the Board of Directors of Medifocus in August 2010. He is a Director of Harmony Asset Limited, a publicly listed investment company specializing in China and Hong Kong. He is also Chairman of Harmony Asset Management Limited, which is the investment manager of Harmony Asset Limited. Dr. Chow is Executive Director of Kaisun Energy Group Ltd. and a Director of Celsion Corporation. Dr. Chow has extensive experience in managing public listed companies that are involved in manufacturing, marketing and financial services, and specializes in mergers and acquisitions. From 1990-1998, Dr. Chow was the Chief Executive Officer of Allied Group of Companies. Prior to this, Dr. Chow held a management position of Brunswick Corporation and Outboard Marine Corporation, and was responsible for all business activities in South East Asia and China.
Dr. Raymond C.F. Tong – Director
Dr Raymond C. F. Tong, M.D., 56, is the Chief Executive Officer of Harmony Medical Inc, an Asian investment group active in the introduction and distribution of medical and healthcare products and services in China and the Asia. Dr. Tong obtained his medical degree from the University of Toronto. He is also an independent Director of Shanghai CP Guojian Pharmaceutical, the largest bio-pharmaceutical manufacturer in China, and is also Chairman of Shanghai Kedu Healthcare Group, one of the largest medical equipment distributor and third-party service provider in China, representing products from GE, Philips, Siemens and Kodak and other multi-nationals. Dr Tong’s earlier career included senior management positions in China with Pfizer and Ball Corporation. He was also responsible for the Healthcare Investment Division of CITIC Pacific in Hong Kong.